FIRDAPSE

LIVE

Serial Number

86082826

Owner

Biomarin Pharmaceutical Inc.

Attorney

Brooks R. Bruneau

First Use Date

Jan 20, 2015

Filing Date

Oct 4, 2013

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FIRDAPSE Trademark

Serial Number: 86082826 • Registration: 4700764

FIRDAPSE is a trademark filed by Biomarin Pharmaceutical Inc. on October 4, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Biomarin Pharmaceutical Inc. (99 trademarks)

371 Bel Marin Keys Blvd., Suite 210
Novato, CA 94949

Entity Type: 03

BioMarin Huxley Ltd. (2 trademarks)

Dominion House
Nassau , BS

Entity Type: 03

SERB (10 trademarks)

53, rue Villiers de l'Isle Adam
Paris 75020 , FR

Entity Type: 99

Legal Representation

Attorney of Record

Brooks R. Bruneau

2,163 trademarks filed View all →

Correspondence Address

Brooks R. Bruneau FisherBroyles LLP

100 Overlook Center

Second Floor

Princeton, NJ 08540

United States

Trademark Details

Filing Date

October 4, 2013

Registration Date

March 10, 2015

First Use Anywhere

January 20, 2015

First Use in Commerce

January 20, 2015

Published for Opposition

March 25, 2014

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune, neurological, muscular, neuromuscular and cancer-associated diseases and disorders

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jul 30, 2025 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jul 30, 2025 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jul 30, 2025 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 29, 2025 APRE

TEAS SECTION 8 & 9 RECEIVED

Mar 10, 2025 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Mar 10, 2024 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Apr 22, 2021 NAS8

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Apr 22, 2021 8.OK

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 22, 2021 APRE

TEAS SECTION 8 RECEIVED

Jan 27, 2021 ES8R

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

May 6, 2020 ASCK

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Mar 18, 2020 ASGN

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 10, 2020 REM1

REGISTERED-PRINCIPAL REGISTER

Mar 10, 2015 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 3, 2015 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 2, 2015 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jan 29, 2015 SUPC

USE AMENDMENT FILED

Jan 26, 2015 IUAF

TEAS STATEMENT OF USE RECEIVED

Jan 26, 2015 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 13, 2015 EXRA

SOU EXTENSION 1 GRANTED

Jan 12, 2015 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 12, 2015 AITU

FAX RECEIVED

Nov 18, 2014 FAXX

SOU EXTENSION 1 FILED

Nov 17, 2014 EXT1

SOU TEAS EXTENSION RECEIVED

Nov 17, 2014 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 20, 2014 NOAM

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 12, 2014 TCCA

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 25, 2014 NPUB

PUBLISHED FOR OPPOSITION

Mar 25, 2014 PUBO

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 5, 2014 TCCA

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 5, 2014 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 18, 2014 PREV

ASSIGNED TO LIE

Feb 13, 2014 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 24, 2014 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 24, 2014 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 24, 2014 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 24, 2014 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 24, 2014 CNEA

ASSIGNED TO EXAMINER

Jan 20, 2014 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 11, 2013 NWOS

NEW APPLICATION ENTERED

Oct 8, 2013 NWAP

Related Trademarks

More from this Owner

SERB PHARMACEUTICALS

More in Same Class

MTORQ

BIOTEC BIOPLASTICS FOR A BETTER LIFE

TANKOMIZER

RIDI

IIAA INTERNATIONAL INSTITUTE FOR ANTI-AGEING

THE MANY SHADES OF SEXUAL WELLNESS